Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978793 · ClinicalTrials.gov registry record
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 31
- Enrollment target
NCT03978793 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 31 participants.
The verdict
NCT03978793 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.
Interventions
- DEVICE MyTPill, a digital pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2025-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03978793
The ClinicalTrials.gov registry entry for NCT03978793 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MyTPill, a digital pill is the first listed.
NCT03978793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03978793 about?
NCT03978793 is a clinical study titled "MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users". This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.
What is the current status of trial NCT03978793?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2021-02-01. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT03978793?
The interventions under investigation include: MyTPill, a digital pill (DEVICE).
Who is sponsoring clinical trial NCT03978793?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.